“双C”方案对2型糖尿病并发乳腺癌患者血糖水平的影响  

“Double C” in the Treatment of Clinical Applications and Clinical Significance in Breast Cancer Type 2 Diabetes Mellitus

作　　者：佘秀菊 张忠玺 周鹏[2] 余文庆[2] 

机构地区：[1]德阳肿瘤医院,四川德阳618000 [2]德阳市人民医院

出　　处：《中外医学研究》2017年第34期152-154,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:为了检测"双C"方案治疗2型糖尿病并发乳腺癌的临床效果。方法:按照纳入和排除标准选取2011年10月-2014年2月来笔者所在医院就诊的2型糖尿病并发乳腺癌的患者56例进行回顾性研究。其中28例患者为"双C"方案治疗组,另外28例则采用普通注射胰岛素的治疗方法。对两组患者治疗前后的血糖水平进行检测,比较两组患者治疗前后的血糖控制情况,以及血糖波动的幅度,比较两组患者治疗前后24 h内胰岛素使用量、住院时间及患者对治疗效果的满意程度。结果:治疗前两组患者胰岛素使用量比较差异无统计学意义(P>0.05),治疗后两组患者胰岛素使用量比较差异有统计学意义(P<0.05)。手术前两组患者血糖水平和血糖波动幅度比较差异无统计学意义(P>0.05),两组患者手术前后血糖水平和血糖波动幅度比较差异均有统计学意义(P<0.05)。治疗前两组患者糖化血红蛋白水平比较差异无统计学意义(P=1.43),治疗后双C组患者Hb A1c水平明显低于对照组,差异有统计学意义(P=0.03)。双C组患者住院时间和满意度均优于对照组患者,差异均有统计学意义(P<0.05)。结论:使用"双C"方案对2型糖尿病并发乳腺癌具有良好的临床治疗效果,并且要优于普通治疗方法。Objective： To test the ＂double C＂ in the treatment of type 2 diabetes mellitus in breast cancer clinical results.Method： According to inclusion and exclusion criteria, 56 cases of type 2 diabetes meUitns in patients with breast cancer to the author＇s hospital from October 20l 1 to February 20f4were studied retrospectively.28 patients were ＂double C＂ in the treatment group, while 28 cases were common treatments using insulin injections.The blood glucose levels in the two groups of patients before and after testing, blood glucose control before and after comparison of two groups of patients, as well as the magnitude of fluctuations in blood sugar, 24 h in the amount of insulin using two groups were compared before and after treatment, hospitalization and patient satisfaction with the treatment effect degree.Result： There was no statistically significant difference in insulin use between the two groups（P〉0.05）, while there was statistically significant difference in insulin use between the two groups after treatment（P〈0.05）.Tbere was no statistically significant difference between the blood glucose levels and the blood glucose fluctuation in the two groups before the operation（P〉O.05）, the differences in blood glucose level and blood glucose fluctuation were statistically significant between the two groups（P〈0.05）.There was no significant difference in glycosylated hemoglobin levels in the two groups before treatment（P=1.43）, after treatment the level of HbAlc was significantly lower than that in the control group, the difference was significant（P=0.03）.The Length of stay and patient satisfaction in double C group were better than the control group, the differences were statistically significant （P〈0.05）.Conclusion： ＂ Double C＂ program for type 2 diabetes mellitus with breast cancer have good clinical results, and superior to ordinary treatment.

关 键 词：“双C”方案 2型糖尿病 乳腺癌 

分 类 号：R587.1[医药卫生—内分泌] R737.9[医药卫生—内科学]